Avax Techs 053484AC5 Bond
Avax Techs' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Avax Techs' financial risk is the risk to Avax Techs stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Avax |
Popular Name | Avax Techs AVB 19 01 DEC 28 |
Equity ISIN Code | US0534953056 |
Bond Issue ISIN Code | US053484AC59 |
Avax Techs Outstanding Bond Obligations
Boeing Co 2196 | US097023DG73 | Details | |
MPLX LP 52 | US55336VAL45 | Details | |
AVALONBAY CMNTYS INC | US05348EAY59 | Details | |
AVALONBAY CMNTYS INC | US05348EAZ25 | Details | |
AVALONBAY CMNTYS INC | US05348EBA64 | Details | |
AVALONBAY CMNTYS INC | US05348EBB48 | Details | |
AVB 19 01 DEC 28 | US053484AC59 | Details | |
AVB 205 15 JAN 32 | US053484AB76 | Details | |
AVALONBAY CMNTYS INC | US05348EAW93 | Details | |
AVALONBAY CMNTYS INC | US05348EAX76 | Details | |
AVALONBAY CMNTYS INC | US05348EAU38 | Details | |
AVALONBAY CMNTYS INC | US05348EAV11 | Details | |
AVALONBAY CMNTYS INC | US05348EBE86 | Details | |
AVB 5 15 FEB 33 | US053484AD33 | Details | |
US05348EBF51 | US05348EBF51 | Details | |
AVALONBAY CMNTYS INC | US05348EBC21 | Details | |
US05348EBG35 | US05348EBG35 | Details | |
US05348EBH18 | US05348EBH18 | Details |
Understaning Avax Techs Use of Financial Leverage
Avax Techs' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Avax Techs' current equity. If creditors own a majority of Avax Techs' assets, the company is considered highly leveraged. Understanding the composition and structure of Avax Techs' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania. Avax Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people. Please read more on our technical analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avax Stock Analysis
When running Avax Techs' price analysis, check to measure Avax Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avax Techs is operating at the current time. Most of Avax Techs' value examination focuses on studying past and present price action to predict the probability of Avax Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avax Techs' price. Additionally, you may evaluate how the addition of Avax Techs to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.